CHU HOPITAUX DE BORDEAUX -  

Ranking results:

Past rankings:

2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2021-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 9
As coordinator: 0
As participant: 8
Sole participant: 1
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 6.093.743 1.512.043 1
2020 0 150.000 0 1
2017 0 5.913.923 159.820 1
2016 0 19.084.187 460.000 2
2015 0 6.338.259 1.700 1
2013 0 5.999.706 328.764 1
2012 194.564 5.975.821 538.949 1 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE3
ELI LILLY AND COMPANY LIMITED2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
ITASUOMEN YLIOPISTO2
SERVICIO MADRILENO DE SALUD2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
UNIVERSITAETSKLINIKUM FREIBURG2
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF2
UNIVERSITE DE BORDEAUX2
ABBVIE INC1
AC IMMUNE1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACADEMISCH ZIEKENHUIS LEIDEN1
ACADEMISCH ZIEKENHUIS MAASTRICHT1
AFFIRIS1
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN1
ALGEMEEN ZIEKENHUIS SINTJAN BRUGGEOOSTENDE AUTONOME VERZORGINSINSTELLING1
ALZHEIMER EUROPE1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIATION GROUPE ESSEC1
ASSOCIATION MARIE LANNELONGUE1
ASTELLAS PHARMA EUROPE BV1
BARTS AND THE LONDON NHS TRUST1
BAYER PHARMA1
BAYLOR COLLEGE OF MEDICINE1
BIOGEN IDEC LIMITED1
BIOLUTION1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE BESANCON1
CENTRE HOSPITALIER SAINTE ANNE DE PARIS1
CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE1
CHU COTE DE NACRE CAEN1
CONSORCIO DE APOYO A LA INVESTIGACION BIOMEDICA EN RED1
DEUTSCHES HERZZENTRUM MUNCHEN1
DIABETES FRAIL1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ETABLISSEMENT FRANCAIS DU SANG1
F HOFFMANNLA ROCHE1
FAKULTNI NEMOCNICE U SV ANNY V BRNE1
FARAPULSE INC1
FINOVATIS1
FORSCHUNGSZENTRUM JULICH1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DOCTOR JOSEP TRUETA1
FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINA1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU1
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON1
GE HEALTHCARE LIMITED1
GOETEBORGS UNIVERSITET1
H LUNDBECK AS1
HEXABIO SARL1
HISTOCELL SL1
HOSPICES CIVILS DE LYON1
IGEN BIOTECH SL1
INSEL GRUPPE1
INSTITUT KLINICKE A EXPERIMENTALNI MEDICINY1
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI1
IXICO TECHNOLOGIES LIMITED1
JANSSEN PHARMACEUTICA NV1
JDRF INTERNATIONAL1
KITE INNOVATION LIMITED1
KLINIKUM DER UNIVERSITAET REGENSBURG1
KOBENHAVNS UNIVERSITET1
LIPOTYPE1
LIVERPOOL HEART AND CHEST HOSPITAL NHS FOUNDATION TRUST1
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
LUNDS UNIVERSITET1
MEDIZINISCHE UNIVERSITAET INNSBRUCK1
MEDIZINISCHE UNIVERSITAET WIEN1
MEDIZINISCHE UNIVERSITAT GRAZ1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
MODUS RESEARCH AND INNOVATION LIMITED1
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE1
NEMOCNICE NA HOMOLCE1
NICHE SCIENCE & TECHNOLOGY1
NOVADISCOVERY1
NOVARTIS PHARMA1
NOVO NORDISK1
OREBRO LANS LANDSTING1
OSPEDALE SAN RAFFAELE1
OY MEDFILES1
PIRKANMAA HOSPITAL DISTRICT1
PROSENEX AMBULATORIUM BETRIEBSGMBH1
REGION HOVEDSTADEN1
RHONKLINIKUM1
RIJKSUNIVERSITEIT GRONINGEN1
SANOFIAVENTIS DEUTSCHLAND1
SECONDA UNIVERSITA DEGLI STUDI DI NAPOLI1
SERVICIO ANDALUZ DE SALUD1
SERVICIO DE SALUD DE CASTILLA LA MANCHA1
SERVIZO GALEGO DE SAUDE1
SIB INSTITUT SUISSE DE BIOINFORMATIQUE1
SKANE LANS LANDSTING1
SLASKIE CENTRUM CHOROB SERCA W ZABRZU1
SOCIETE EUROPEENNE DE CARDIOLOGIE1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL1
TAKEDA DEVELOPMENT CENTRE EUROPE1
TAMPEREEN KORKEAKOULUSAATIO SR1

Constancy:

Total number of partners: 142
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 139
Frequent / Rare Partner Ratio: 0.02

Project overview:

Start dateProjectacronymrolefundingpartners
2021-03-01Ground-BrEAking Electroporation-based inTervention for Atrial Fibrillation treatment (BEAT AF) BEAT AFparticipant6.093.7439
2020-12-01Computed tomography targets for efficient guidance of catheter ablation in ventricular tachycardia MAP-IN-HEARTparticipant150.0002
2017-01-01Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally-Invasive Segmental Artery Coil-Embolization’: A Randomized Controlled Multicentre Trial PAPA-ARTISparticipant5.913.92326
2016-11-01Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020 ROADMAPparticipant3.998.25026
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2015-09-01REgenerative Stem cell therapy for STroke in Europe RESSTOREparticipant6.338.25931
2013-10-01Reach α-synuclein-dependent neurodegeneration: clinical development of therapeutic AFFITOPE vaccines for Parkinson’s disease and multisystem atrophy SYMPATHparticipant5.999.7068
2012-05-01Application of MRI to explore myocardial structural reorganisation accompanying contraction and the influence of this on arrhythmogenesis the normal and post infarct heart MSIAcoordinator194.5641
2012-03-01A RANDOMIZED CLINICAL TRIAL TO EVALUATE THE EFFECTIVENESS OF A MULTI-MODAL INTERVENTION IN OLDER PEOPLE WITH TYPE 2 DIABETES ON FRAILTY AND QUALITY OF LIFE: THE MID-FRAIL STUDY MID-FRAIL-STUDYparticipant5.975.82117